SAM
WST icon

SEB Asset Management’s West Pharmaceutical WST Stock Holding History

SEB Asset Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.11M Buy
14,242
+764
+6% +$234K 0.02% 463
2026
Q1 		$3.38M Buy
+13,478
New +$3.35M 0.01% 516

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SEB Asset Management's WST Position: Q2 2026 in Review

SEB Asset Management increased its West Pharmaceutical (WST) stake by 5.7% in Q2 2026, buying an estimated $234K and bringing the position to 14,242 shares worth $5.11M. The position accounts for 0.02% of the portfolio, ranked #463.

SEB Asset Management first reported a position in WST in Q1 2026 and has held it in 2 quarters since. 785 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • SEB Asset Management held 14,242 shares of West Pharmaceutical worth $5.11M as of Q2 2026.
  • SEB Asset Management bought 764 West Pharmaceutical shares in Q2 2026, an estimated $234K.
  • West Pharmaceutical made up 0.02% of SEB Asset Management's portfolio in Q2 2026, its #463 holding.
  • SEB Asset Management first reported a position in West Pharmaceutical in Q1 2026 and has held it in 2 quarters since.
  • 785 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on SEB Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.